James Chubb

Biography

James Chubb, Ph.D. is broadly experienced in operational management, strategy and financing of biopharmaceutical companies, as well as possessing extensive pharmaceutical product development experience. As a senior executive at Glaxo with more than 12 years of experience, Dr. Chubb was responsible for directing the filing of more than 15 NDA's and ANDs for anti-bacterial and anti-fungal drugs, beta agonist bronchodilators and inhaled steroids for asthma, topical steroids for dermatological indications and serotonin antagonists for cancer induced nausea and vomiting. As President and Chief Executive of Triplex Pharmaceuticals and its successor, Aronex Pharmaceuticals, for 8 years, Dr Chubb raised over $65 million in financing, and established several corporate partnerships. He built a strong management team and over saw advancement of three cancer drugs and an anti fungal into clinical trials. Dr. Chubb was subsequently founder and principal of ProPharma International Partners, Inc, a consulting and advisory service company to biotechnology companies, with locations in the San Francisco Bay area and London, UK. Dr. Chubb received his Ph.D. in Pharmacology from the University of Arizona College of Medicine and completed a cardiovascular research fellowship at Michigan State University.

Research Interest

Healthcare